First Trust Advisors LP Sells 11,702 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

First Trust Advisors LP lowered its holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) by 9.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 106,912 shares of the company’s stock after selling 11,702 shares during the period. First Trust Advisors LP owned approximately 0.27% of Viemed Healthcare worth $857,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Rice Hall James & Associates LLC bought a new stake in Viemed Healthcare during the 4th quarter valued at $2,083,000. First Eagle Investment Management LLC raised its stake in shares of Viemed Healthcare by 196.5% during the 4th quarter. First Eagle Investment Management LLC now owns 328,824 shares of the company’s stock valued at $2,637,000 after purchasing an additional 217,923 shares during the period. Arrowstreet Capital Limited Partnership bought a new position in Viemed Healthcare in the 4th quarter worth about $1,549,000. JPMorgan Chase & Co. boosted its stake in Viemed Healthcare by 131.4% in the 4th quarter. JPMorgan Chase & Co. now owns 228,652 shares of the company’s stock worth $1,834,000 after purchasing an additional 129,854 shares during the period. Finally, Trexquant Investment LP purchased a new position in Viemed Healthcare during the 4th quarter valued at about $468,000. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

Viemed Healthcare Trading Down 11.7 %

Shares of Viemed Healthcare stock opened at $6.42 on Friday. The company’s 50-day moving average price is $7.12 and its 200-day moving average price is $7.96. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. The company has a market cap of $253.74 million, a price-to-earnings ratio of 23.78 and a beta of 1.49. Viemed Healthcare, Inc. has a 12-month low of $6.21 and a 12-month high of $9.81.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The firm had revenue of $59.10 million during the quarter, compared to the consensus estimate of $60.60 million.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.